CFO at NeuroSense Therapeutics.
Mr. Eisenberg is a registered CPA with broad experience in all aspects of public companies in Israel and in the US.
Prior to joining NeuroSense, he served in several financial management positions in the biotech industry, including CFO and acting CEO of Wize Pharma Inc.
Prior to that, Or served as controller of the Katzir Fund Group, following his position as external Chief Financial Officer for a number of public companies whose shares are listed for trading on the TASE.
Mr. Eisenberg began his career as an accountant at Ernst & Young.
B.A. in Economics and Accounting from Haifa University, and Certified Public Accountant.
